Type I interferon and neutrophil transcripts in lupus nephritis renal biopsies: clinical and histopathological associations.
Mavragani CP, Kirou KA, Seshan SV, Crow MK.
Rheumatology (Oxford). 2023 Jul 5;62(7):2534-2538. doi: 10.1093/rheumatology/keac641.
High Systemic Type I Interferon Activity Is Associated With Active Class III/IV Lupus Nephritis.
Iwamoto T, Dorschner JM, Selvaraj S, Mezzano V, Jensen MA, Vsetecka D, Amin S, Makol A, Osborn T, Moder K, Chowdhary VR, Izmirly P, Belmont HM, Clancy RM, Buyon JP, Wu M, Loomis CA, Niewold TB.
J Rheumatol. 2022 Apr;49(4):388-397. doi: 10.3899/jrheum.210391. Epub 2021 Nov 15.
Bullous systemic lupus erythematosus in females.
Sprow G, Afarideh M, Dan J, Hedberg ML, Werth VP.
Int J Womens Dermatol. 2022 Jul 25;8(3):e034. doi: 10.1097/JW9.0000000000000034. eCollection 2022 Oct.
Crescentic glomerulonephritis in children.
Mayer U, Schmitz J, Bräsen JH, Pape L.
Pediatr Nephrol. 2020 May;35(5):829-842. doi: 10.1007/s00467-019-04436-y. Epub 2020 Feb 12.
Sequential therapy for diffuse proliferative and membranous lupus nephritis: cyclophosphamide and prednisolone followed by azathioprine and prednisolone.
Chan TM, Li FK, Wong RW, Wong KL, Chan KW, Cheng IK.
Nephron. 1995;71(3):321-7. doi: 10.1159/000188739.
Rituximab therapy in lupus nephritis: current clinical evidence.
Ramos-Casals M, Diaz-Lagares C, Soto-Cardenas MJ, Brito-Zeron P, Cuadrado MJ, Sanna G, Bertolaccini L, Khamashta MA.
Clin Rev Allergy Immunol. 2011 Jun;40(3):159-69. doi: 10.1007/s12016-010-8205-3.
[Long-term outcome of type V lupus membranous glomerulonephritis].
Pastén V R, Massardo V L, Rosenberg G H, Radrigán A F, Roessler B E, Valdivieso D A, Jacobelli G S.
Rev Med Chil. 2005 Jan;133(1):23-32. doi: 10.4067/s0034-98872005000100004. Epub 2005 Mar 10.
Immune gene expression and functional networks in distinct lupus nephritis classes.
Gilmore AC, Wilson HR, Cairns TD, Botto M, Lightstone L, Bruce IN, Terence Cook H, Pickering MC; MASTERPLANS Consortium.
Lupus Sci Med. 2022 Jan;9(1):e000615. doi: 10.1136/lupus-2021-000615.
Clinical significance of exostosin 1 in confirmed and suspected lupus membranous nephropathy.
Ye T, Jiang M, Zeng X, Zong D, Du Y, Li X, Huang B, Tang X.
Lupus Sci Med. 2023 Dec 28;10(2):e001051. doi: 10.1136/lupus-2023-001051.
Membranous glomerulonephritis development with Th2-type immune deviations in MRL/lpr mice deficient for IL-27 receptor (WSX-1).
Shimizu S, Sugiyama N, Masutani K, Sadanaga A, Miyazaki Y, Inoue Y, Akahoshi M, Katafuchi R, Hirakata H, Harada M, Hamano S, Nakashima H, Yoshida H.
J Immunol. 2005 Dec 1;175(11):7185-92. doi: 10.4049/jimmunol.175.11.7185.
